Abstract
On April 5, 2015, the first genome editing of human embryos was reported. The genome of an organism is the sum total of its DNA; to edit a genome is to make a highly specific change to it. The paper, by a group of Chinese researchers, used a new technology known as CRISPR-Cas9 (the embryos in question were intentionally chosen to be non-viable). This application came just three years after the technology's genesis.1 Although the possibility of modifying genomes had been around for several decades, CRISPR-Cas9 is on the verge of making this a much more powerful reality. Not only is the technology effective, it is also very low cost and accessible.

This publication has 6 references indexed in Scilit: